Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages

Virology

Volumn 440, Issue 1, 2013, Pages 19-30

  Arcangeletti, Maria Cristina ^a   Germini, Diego ^a   Rodighiero, Isabella ^a   Mirandola, Prisco ^a   De Conto, Flora ^a   Medici, Maria Cristina ^a   Gatti, Rita ^a   Chezzi, Carlo ^a   Calderaro, Adriana ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Cell cycle; HCMV; Toll like receptor 4

Indexed keywords

BETA INTERFERON; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EMBRYO; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MACROPHAGE FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS REPLICATION;

CELL CYCLE; CELL LINE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; MACROPHAGES; TOLL-LIKE RECEPTOR 4; ULTRAVIOLET RAYS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 84876411483     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.01.021     Document Type: Article

References (76)

1. Adler B., Sinzger C. Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread?. Thromb. Haemost 2009, 102(6):1057-1063.
2. Alford C.A., Britt W.J. Cytomegalovirus. Fields Virology 1996, 2493-2534. Lippincott-Raven Publishers, Philadelphia. third ed. D. Knipe, P. Howley (Eds.).
3. Arcangeletti M.C., De Conto F., Ferraglia F., Pinardi F., Gatti R., Orlandini G., Calderaro A., Motta F., Medici M.C., Valcavi P., Razin S.V., Chezzi C., Dettori G. Human cytomegalovirus proteins pp65 and IEp72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts. J. Cell. Biochem. 2003, 90(5):1056-1067.
4. Arcangeletti M.C., Rodighiero I., Mirandola P., De Conto F., Covan S., Germini D., Razin S., Dettori G., Chezzi C. Cell-cycle-dependent localization of human cytomegalovirus UL83 phosphoprotein in the nucleolus and modulation of viral gene expression in human embryo fibroblasts in vitro. J. Cell. Biochem. 2011, 112(1):307-317.
5. Arrode G., Devrinche C. Dendritic cells and HCMV cross-presentation. Curr. Top. Microbiol. Immunol. 2003, 276:277-294.
6. Bain M., Sinclair J. The S phase of the cell cycle and its perturbation by human cytomegalovirus. Rev. Med. Virol 2007, 17(6):423-434.
7. Billstrom Schroeder M., Christensen R., Worthen G.S. Human cytomegalovirus protects endothelial cells from apoptosis induced by growth factor withdrawal. J. Clin. Virol. 2002, 25(Suppl. 2):149-157.
8. Boheme K.W., Compton T. Innate sensing of viruses by toll-like receptors. J. Virol. 2004, 78(15):7867-7873.
9. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol 2006, 177(10):7094-7102.
10. Bosch W., Heckmanb M.G., Diehlb N.N., Shalevc J.A., Pungpapongd S., Hellingera W.C. Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients. Am. J. Transplant. 2011, 11(10):2181-2189.
11. Bresnahan W.A., Boldogh I., Thompson E.A., Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996, 224(1):150-160.
12. Bruggeman L.A. Viral subversion mechanisms in chronic kidney disease pathogenesis. Clin. J. Am. Soc. Nephrol 2007, 2(Suppl. 1):13-19.
13. Cai M.S., Li M.L., Zheng C.F. Herpesviral infection and Toll-like receptor 2. Protein Cell 2012, 3(8):590-601.
14. Castillo J.P., Kowalik T.F. HCMV infection: modulating the cell cycle and cell death. Int. Rev. Immunol. 2004, 23(1-2):113-139.
15. Cervera C., Lozano F., Saval N., Gimferrer I., Ibanez A., Suarez B., Linares L., Cofan F., Ricart M.J., Esforzado N., Marcos M.A., Pumarola T., Oppenheimer F., Campistol J.M., Moreno A. The influence of innate immunity gene receptors polymorphisms in renal transplantation infection. Transplantation 2007, 83(11):1493-1500.
16. Chang W.L., Barry P.A. Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc. Natl. Acad. Sci. U.S.A 2010, 107(52):22647-22652.
17. Chiang C.Y., Veckman V., Limmer K., David M. Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J. Biol. Chem 2011, 287(6):3704-3709.
18. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., Nabors L.B., Cobbs C.G., Britt W.J. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62(12):3347-3350.
19. Compton T., Kurt-Jones E., Boheme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J. Virol. 2003, 77(8):4588-4596.
20. Dittmer D., Mocarski E.S. Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 1997, 71(2):1629-1634.
21. Ducloux D., Deschamps M., Yannaraki M., Ferrand C., Bamoulid J., Saas P., Kazory A., Chalopin J.M., Tiberghien P. Relevance of Toll-like receptor 4 polymorphisms in renal transplantation. Kidney Int. 2005, 67(6):2454-2461.
22. Fortunato E.A., Sanchez V., Yen J.Y., Spector D.H. Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J. Virol 2002, 76(11):5369-5379.
23. Friboulet L., Gourzones C., Tsao S.W., Morel Y., Paturel C., Temam S., Uzan C., Busson P. Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells. BMC Cancer 2010, 10:327-340.
24. Gale M., Tan S.L., Katze M.G. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 2000, 64(2):239-280.
25. Gaur P., Munjhal A., Lal S.K. Influenza virus and cell signaling pathways. Med. Sci. Monit. 2011, 17(6):148-154.
26. Gobbi G., Ricci F., Malinverno C., Carubbi C., Pambianco M., Panfilis G., Vitale M., Mirandola P. Hydrogen sulfide impairs keratinocyte cell growth and adhesion inhibiting mitogen-activated protein kinase signaling. Lab. Invest. 2009, 89(9):994-1006.
27. Hagemeier C., Caswell R., Hayhurst G., Sinclair J., Kouzarides T. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 1994, 13(12):2897-2903.
28. Harwani S.C., Lurain N.S., Zariffard M.R., Spear G.T. Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue. Virol. J 2007, 4:133-142.
29. Hasan A.U., Caux C., Perrot I., Doffin A.C., Menetrier-Caux C., Trinchieri G., Tommasino M., Vlach J. Cell proliferation and survival induced by Toll-like receptors is antagonized by type one IFNs. Proc. Nat. Acad. Sci U.S.A 2007, 104(19):8047-8052.
30. Hasan A.U., Trinchieri G., Vlach J. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J. Biol. Chem. 2005, 280(21):20620-20627.
31. Hertel L., Mocarski E.S. Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of pseudomitosis independent of US28 function. J. Virol 2004, 78(21):11988-12011.
32. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168(9):4531-4537.
33. Husebye H., Halaas O., Stenmark H., Tunheim G., Sandanger O., Bogen B., Brech A., Latz E., Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 2006, 25(4):683-692.
34. Hwang H.C., Clurman B.E. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005, 24:2776-2786.
35. Ioudinkova E., Arcangeletti M.C., Rynditch A., De Conto F., Motta F., Covan S., Pinardi F., Razin S.V., Chezzi C. Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 2006, 384:120-128.
36. Iversen A.C., Steinkjer B., Nilsen N., Bohnhorst J., Moen S.H., Vik R., Stephens P., Thomas D.W., Benedict C.A., Espevik T. A proviral role for CpG in cytomegalovirus infection. J. Immunol. 2009, 182(9):5672-5681.
37. Jault F.M., Jault J.M., Ruchti F., Fortunato E.A., Clark C., Corbeil J., Richman D.D., Spector D.H. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 1995, 69(11):6697-6704.
38. Jiang H., Wang P.Z., Zhang Y., Xu Z., Sun L., Wang L.M., Huang C.X., Lian J.Q., Jia Z.S., Li Z.D., Bai X.F. Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 2008, 380(1):52-59.
39. Katayama T., Nakanishi K., Nishihara H., Kamiyama N., Nakagawa T., Kamiyama T., Iseki K., Tanaka S., Todo S. Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells. Int. J. Oncol. 2007, 31(3):613-620.
40. Kovacs I.J., Hegedus K., Pal A., Pusztai R. Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. Placenta 2007, 28(7):620-623.
41. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A 2004, 101(5):1315-1320.
42. Lihn A.S., Richelsen B., Pedersen S.B., Haugaard S.B., Rathje G.S., Madsbad S., Andersen O. Increased expression of TNF-α, IL-6, and IL-8 in HALS:implications for reduced adiponectin expression and plasma levels. Am. J. Physiol. Endocrinol. Metab. 2003, 285(5):1072-1080.
43. Löfgren J., Marttila R., Renko M., Rämet M., Hallman M. Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics. Pediatr. Pulmonol. 2010, 45(7):687-692.
44. Lunardi C., Bason C., Corrocher R., Puccetti A. Induction of endothelial cell damage by HCMV molecular mimicry. Trends Immunol. 2005, 26(1):19-24.
45. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seyaa T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 2002, 293(5):1364-1369.
46. Mendelson M., Monard S., Sissons P., Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 1996, 77(pt. 12):3099-3102.
47. Mirandola P., Sponzilli I., Solenghi E., Micheloni C., Rinaldi L., Gobbi G., Vitale M. Down-regulation of human leukocyte antigen class I and II and beta 2-microglobulin expression in human herpesvirus-7-infected cells. J. Infect. Dis. 2006, 193(7):917-926.
48. Mocarski E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends. Microbiol. 2002, 10(7):332-339.
49. Mocarski E.S. Virus self-improvement through inflammation:no pain, no gain. Proc. Nat. Acad. Sci. U.S.A. 2002, 99(6):3362-3364.
50. Mocarski E.S., Courcelle C.T. Cytomegalovirus and their replication. Fields Virology 2001, 2629-2673. Lippincott-Raven Publishers, Philadelphia. fourth ed. D. Knipe, P. Howley (Eds.).
51. Opitz B., Vinzing M., van Laak V., Schmeck B., Heine G., Gunther S., Preissner R., Slevogt H., N'Guessan P.D., Eitel J., Goldmann T., Flieger A., Suttorp N., Hippenstiel S. Legionella pneumophila induces IFNΒ in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J. Biol. Chem. 2006, 281(47):36173-36179.
52. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11(3):961-971.
53. Palazzo M., Gariboldi S., Zanobbio L., Dusio G.F., Selleri S., Bedoni M., Balsari A., Rumio C. Cross-talk among toll-like receptors and their ligands. Int. Immunol. 2008, 20(5):709-718.
54. Pass R.F. Cytomegalovirus. Fields Virology 2001, 2575-2705. Lippincott-Raven Publishers, Philadelphia. fourth ed. D. Knipe, P. Howley (Eds.).
55. Poma E.E., Kowalik T.F., Zhu L., Sinclair J.H., Huang E.S. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol 1996, 70(11):7867-7877.
56. Ramsay M.E., Miller E., Peckham C.S. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch. Dis. Child. 1991, 66(9):1068-1069.
57. Razonable R.R., Paya C.V. Herpesvirus infections in transplant recipients: current challenges in the clinical management fo cytomegalovirus and Epstein-Barr virus infections. Herpes 2003, 10(3):60-65.
58. Rölle A., Olweus J. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures. A.P.M.I.S 2009, 117(5-6):413-426.
59. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79(6):3350-3357.
60. Salsman J., Jagannathan M., Paladino P., Chan P.K., Dellaire G., Raught B., Frappier L. Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J. Virol. 2012, 86(2):806-820.
61. Sinclair J., Baillie J., Bryant L., Caswell R. Human cytomegalovirus mediates cell cycle progression through G1 into early S phase in terminally differentiated cells. J. Gen. Virol. 2000, 81(pt.6):1553-1565.
62. Sinclair J., Sissons P. Latency and reactivation of human citomegalovirus. J. Gen. Virol. 2006, 87(pt. 7):1763-1779.
63. Slobedman B., Stern J.L., Cunningham A.L., Abendroth A., Abate D.A., Mocarski E.S. Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J. Virol. 2004, 78(8):4054-4062.
64. Smith M.S., Bentz G.L., Alexander J.S., Yurochko A.D. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 2004, 78(9):4444-4453.
65. Söderberg-Nauclér C., Streblow D.N., Fish K.N., Allan-Yorke J., Smith P.P., Nelson J.A. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J. Virol. 2001, 75(16):7543-7554.
66. Song Y.J., Stinski M.F. Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. J. Virol 2005, 79(4):2597-2603.
67. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol 1994, 68(3):1597-1604.
68. Varani S., Landini M.P. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2011, 2(1):6-20.
69. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003, 36:131-149.
70. West J., Damania B. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J. Virol 2008, 82(11):5440-5449.
71. Wiebusch L., Asmar J., Uecker R., Hagemeier C. Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells. J. Gen. Virol 2003, 84(pt 1):51-60.
72. Wolf J., Weinberger B., Grubeck-Loebenstein B. The immunoregulatory effects of CMV infection in human fibroblasts and the impact on cellular senescence. Immun. Ageing 2012, 9:1-6.
73. Xagorari A., Chlichlia K. Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol. J 2008, 2:49-59.
74. Xia C., Lu M., Zhang Z., Meng Z., Zhang Z., Shi C. TLRs antiviral effect on hepatitis B virus in HepG2 cells. J. Appl. Microbiol. 2008, 105(5):1720-1727.
75. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147(4):868-880.
76. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of toll-like receptor mRNA in leukocytes in response to microbes, their production, and cytokines. J. Immunol 2002, 168(2):554-561.